Blocking apoptotic damage after a heart attack.
Veggeberg
S
S
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D004285:Dogs; D004357:Drug Synergism; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology; D010712:Phosphatidic Acids / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011518:Proto-Oncogene Proteins / Q000627:therapeutic use; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein
D010712:Phosphatidic Acids; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein; D011092:Polyethylene Glycols